BATRK ATL Braves stock climbs 279 percent despite Q4 2025 EPS miss that fell short of analyst estimates UBXG UBX CEO prioritizes global market expansion forecasting doubledigit revenue growth for the full year Pfizer Inc PFE Strategic CDK Inhibitor Supply Partnership with Relay Therapeutics Validates Atirmociclib Commercial Potential in Metastatic Breast Cancer